The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Arbidol as a broad-spectrum antiviral: An update
Open accessAbstract
Highlights • Arbidol (ARB) is licensed in Russia and China for the treatment of influenza and other viral infections.• ARB inhibits a large panel of viral pathogens, enveloped or not.• ARB displays a dual binding activity to lipid membranes and to viral or cellular proteins.• It blocks viral endocytosis and replication in membranous intracellular compartments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., Huang, Y., Qi, Y., Peng, B., Wang, H., et al. (2012) · eLife · doi:10.7554/elife.00049 · Cited by 2,115
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
Virus entry by macropinocytosis
Mercer, J., & Helenius, A. (2009) · Nature Cell Biology · doi:10.1038/ncb0509-510 · Cited by 816
von Kleist, L., Stahlschmidt, W., Bulut, H., Gromova, K., Puchkov, D., Robertson, M. J., MacGregor, K. A., Tomilin, N., Pechstein, A., Chau, N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.025 · Cited by 573
Romero-Brey, I., Merz, A., Chiramel, A., Lee, J.-Y., Chlanda, P., Haselman, U., Santarella-Mellwig, R., Habermann, A., Hoppe, S., Kallis, S., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003056 · Cited by 518
Assembly of infectious hepatitis C virus particles
Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.005 · Cited by 453
High-Performance Liquid Chromatography
(2002) · Analytical Chemistry for Technicians · doi:10.1201/9781420056709-21 · Cited by 420
Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
Boriskin, Y., Leneva, I., Pecheur, E.-I., & Polyak, S. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784049658 · Cited by 410
Self-citationHepatitis C Virus E2 Envelope Glycoprotein Core Structure
Kong, L., Giang, E., Nieusma, T., Kadam, R. U., Cogburn, K. E., Hua, Y., Dai, X., Stanfield, R. L., Burton, D. R., Ward, A. B., et al. (2013) · Science · doi:10.1126/science.1243876 · Cited by 398
Replication cycle of chikungunya: A re-emerging arbovirus
Solignat, M., Gay, B., Higgs, S., Briant, L., & Devaux, C. (2009) · Virology · doi:10.1016/j.virol.2009.07.024 · Cited by 384
Cited by
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
Kadam, R. U., & Wilson, I. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617020114 · Cited by 435
Clinical trials on drug repositioning for COVID-19 treatment
Rosa, S. G. V., & Santos, W. C. (2020) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2020.40 · Cited by 420
Interferon-α2b Treatment for COVID-19
Zhou, Q., Chen, V., Shannon, C. P., Wei, X.-S., Xiang, X., Wang, X., Wang, Z.-H., Tebbutt, S. J., Kollmann, T. R., & Fish, E. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01061 · Cited by 417
Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Wang, X., Yang, H., Hong, L., Wu, N., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00568-6 · Cited by 300
Metadata
- Authors
- Blaising, J., Polyak, S. J., & Pécheur, E.-I.
- Venue
- Antiviral Research
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 107
- Pages
- 84-94
- ISSN
- 0166-3542 (ISSN-L)
- OpenAlex
- W1987665528
- Cited by
- 485
- References
- 41
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Arbidol as a broad-spectrum antiviral: An update. https://app.cochat.ai/papers/10.1016/j.antiviral.2014.04.006
- The paper
- Blaising, J., Polyak, S. J., & Pécheur, E.-I. (2014). Arbidol as a broad-spectrum antiviral: An update. Antiviral Research. https://doi.org/10.1016/j.antiviral.2014.04.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
